Ingabe usukhulile kakhulu ukwelashwa?
Uma kuziwa eminyakeni, i-multiple sclerosis (MS) ayikubandlululi. Nakuba abantu abaningi bephakathi kuka-20 no-50 uma betholakala, ngokusho kwe-National MS Society lesi sifo singabashaya abantu asebekhulile. Uma usanda kuthola ukuthi unayo i-MS futhi usekuphakathi kwakho kwama-50 noma ama-60 noma ngaphesheya, kungenzeka ukuthi awunakho ukwelashwa okufanayo njengomuntu osemncane, kodwa lokhu akusho ukuthi awunazo izinketho nhlobo.
Wena kanye ne-neurologist yakho uzodlula phezu kwamasu okuphatha i-MS ezosebenza kakhulu kuwe, kodwa akulimazi ukuba nolwazi olulandelayo uma uhlala phansi ukuze uxoxe nabo. Nakhu okunye okumele ukwazi nge- MS zokwelashwa kubantu abadala.
Indlela Uhlobo Lwe-MS Elikhetha Ngayo Ukwelapha
Abantu abaningi abathuthukisa i- MS kamuva ekuphileni banesimo esiqhubekayo sesifo, lapho kunciphisa kancane futhi okuqhubekayo emsebenzini ngenxa yokulimala okungapheli kwemizwa. Ngokuvamile kuqala ngezinkinga zokuhamba-izinyawo-ukuhudula noma ukuqina komunye umlenze noma zombili imilenze. Phakathi nezinyanga nezinyanga, izinga lokukhubazeka landa.
Lokhu kuqhathaniswa nokubuyiswa kabusha kwe-MS (RRMS) lapho abantu benokukhubazeka okungahambi khona ngezikhathi zomsebenzi ovamile-okwenzeka njengomphumela wokuhlaselwa komzimba wamagciwane e-myelin, umgogodla wokuzivikela ohlanganisa imizwa. Uma ukuhlaselwa sekuphelile, izimpawu ze-MS zingase zinyamalale.
Njengoba kunikezwe umehluko phakathi kwezinhlobo ezimbili eziyinhloko ze-MS, kulula ukubona ukuthi imithi ngayinye ayikwazi kanjani ukusebenza ngenye. Izidakamizwa zokwelapha i-RRMS zibizwa ngokuthi izifo eziguqula izifo (i-DMTs) ezisebenza ngokubhekela amasosha omzimba. Kunemithi engu-15 enikezwe yi-US Food and Drug Administration (FDA) yokwelapha i-RRMS.
Amabili kuphela alawo avunyelwe ukwelapha i-MS eqhubekayo, ngokusho kwe-National MS Society, futhi ngisho nalawo ayamukelekile kuzo zonke izinhlobo zesifo. Kubalulekile ukuphawula ukuthi kunezinhlobo ezintathu ze-MS eqhubekayo: MS (PPMS) eyinhloko-phambili, i-MS eqhubekayo (SPMS), kanye ne-MS eqhubekayo yokuphindaphinda (i-PRMS).
Imithi yokuqala kokubili engasetshenziswa ukuphatha izinhlobo eziqhubekayo ze-MS yi-Ocrevus (ocrelizumab). Lesi sidakamizwa sinikezwa nge-intravenously, 600 mg kanye nezinyanga eziyisithupha, ngaphandle kwesilinganiso sokuqala esihlukaniswe ngamabhiliyoni angu-300 (mg). Isidakamizwa sesibili, i-Novantrone (mitoxantrone), ivunyelwe ukwelapha i-SPMS kanye ne-PRMS (kodwa akukho PPMS). Inikezwa ngama-12 mg amanani njalo ngezinyanga ezintathu.
Njenganoma yimiphi imithi enamandla, zombili lezi mithi zinemiphumela emibi, kubandakanya ezinye ezingabangela inkinga ikakhulu kubantu asebekhulile. I-Ocrevus ingakhuphula izifo zokuphefumula. I-Novantrone, eyayiqala ukwelashwa komdlavuza, iyingozi kakhulu kunoma ubani oye waba ne-chemotherapy noma onezinkinga zenhliziyo ukusebenzisa.
Izidakamizwa ezingezona izidakamizwa
Ngisho noma imishanguzo yezinhlobo ze-MS cishe inomthelela kumuntu omdala kunomkhawulo futhi angeke uphepheke, kunezindlela eziningi zokwelapha ezitholakalayo ukusiza ngezimpawu ze- MS .
Lokhu kufaka phakathi ukwelashwa ngokomzimba ukusiza ukwakha amandla omzimba nokufundisa amasu okukhokhela ukulahlekelwa komsebenzi.
Ukwelapha emsebenzini (OT) kungakusiza ukuguqula ikhaya lakho ukuze ukwazi ukusebenza kangcono ukulinganiselwa kwakho ukuze uzizinakekele. Lokhu kungabandakanya izinto ezifana nokufaka ibhentshi lokugeza lokugeza ebhodini lakho nokulungisa kabusha amakhabethe ekhishi ukuze izinto ezidingayo zifinyelele kalula. Futhi ungafunda izindlela ezahlukene zokuhambisa umzimba wakho nge-OT.
Umthombo
> National Multiple Sclerosis Society. Bulletin yezokwelapha. " Ukuguga nge-Multiple Sclerosis. " 2011.